InfuSystems Holdings Inc is a growing healthcare company, which provides infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from five locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. InfuSystem derives the majority of revenue from treatments for colorectal cancer and rest from treatments for non-colorectal disease states.
| Website: | www.infusystem.com |
| Email: | info@infusystem.com |
| Main Phone: | +1 248 291-1210 |
| Address: | 31700 Research Park Drive |
| State: | MI |
| City / Town: | Madison Heights |
| Country: | USA |
| Postal Code: | 48071 |
| Exchange: | AMX |
| CEO: | Richard DiIorio |
| Employees: | 251 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
As we gear up for the 4th, the summer weeks have historically been "slow" for the markets and especially for micro-cap.
At www.ValuEngine.com we show that the Medical sector 12.6% overvalued with the medical Products industry 10.4% undervalued. All 12 stocks in today’s table have complete ValuEngine data and have
The three major US indexes plunged today, closing deeply in the red following the Standard & Poor's decision to cut its outlook for U.S sovereign debt.The Dow Jones Industrial Average
InfuSystems Holdings Inc is a growing healthcare company, which provides infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from five locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. InfuSystem derives the majority of revenue from treatments for colorectal cancer and rest from treatments for non-colorectal disease states.
| Website: | www.infusystem.com |
| Email: | info@infusystem.com |
| Main Phone: | +1 248 291-1210 |
| Address: | 31700 Research Park Drive |
| State: | MI |
| City / Town: | Madison Heights |
| Country: | USA |
| Postal Code: | 48071 |
| Exchange: | AMX |
| CEO: | Richard DiIorio |
| Employees: | 251 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
As we gear up for the 4th, the summer weeks have historically been "slow" for the markets and especially for micro-cap.
At www.ValuEngine.com we show that the Medical sector 12.6% overvalued with the medical Products industry 10.4% undervalued. All 12 stocks in today’s table have complete ValuEngine data and have
The three major US indexes plunged today, closing deeply in the red following the Standard & Poor's decision to cut its outlook for U.S sovereign debt.The Dow Jones Industrial Average
| Last Price 8.49 | Change $ 0.01 | Change % 0.12 | Tick N/A |
| Bid 8.47 | Bid Size 100.00 | Ask 8.59 | Ask Size 1,200.00 |
| Open 8.37 | High 9.00 | Low 8.23 | Prev Close 8.48 |
| Last Trade | Volume 270,114 | 52 Wk Hi 11.90 | 52 Wk Low 4.00 |
| Market Cap 168.8 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 19,882,136.00 | EPS (TTM) 0.06 | PE Ratio 141.30 | Exchange NYSE American |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 13 | 31 |
| Number of Buys | 12 | 30 |
| Number of Sells | 1 | 1 |
| Net Activity | -2213 | 192508 |
| Last 10 Buys | Shares |
|---|---|
| Christopher R. Sansone | 1,000 |
| Christopher R. Sansone | 1,000 |
| Christopher R. Sansone | 1,000 |
| Christopher R. Sansone | 1,000 |
| Christopher R. Sansone | 1,000 |
| Christopher R. Sansone | 1,000 |
| Christopher R. Sansone | 1,000 |
| Christopher R. Sansone | 1,000 |
| Christopher R. Sansone | 1,000 |
| Christopher R. Sansone | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| David C. Dreyer | 1,000 |
| David C. Dreyer | 1,000 |
| Ryan J Morris | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 2.5 | 2.5 | 2.5 | 2.5 |
| Low Target Price Estimate | 2.5 | 2.5 | 2.5 | 2.5 |
| Mean Target Price Estimate | 2.5 | 2.5 | 2.5 | 2.5 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 03/16/12 | 03/16/12 | 03/16/12 | 03/16/12 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| SC 13D/A | Amendment to a SC 13D filing | 16 | 2018-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-14 |
| DEFA14A | Additional proxy soliciting materials - definitive | 4 | 2018-06-14 |
| DEFC14A | Definitive proxy statement in connection with contested solicitations | 65 | 2018-06-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-07 |
| PREC14A | Preliminary proxy statement containing contested solicitations | 65 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 1 | 1 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait